Table 3. Performances of the four models with different combinations of predictive variables in the derivation and validation cohorts.
Variables | Clinical model | Clinical-pathological model | Clinical-medication model | Full model |
---|---|---|---|---|
Age | 0.998 | |||
Pathological grade | 1.270* | 1.300* | ||
Cystatin C | 2.728* | 2.731* | 2.305* | 2.663* |
eGFR | 0.970* | 0.972* | 0.233 | 0.973 |
BNP | 1.059* | 1.057* | 1.476 | 1.055* |
Log urinary ACR (mg/g) | 1.077* | 1.066* | 1.517* | 1.066 |
RASB use | 0.841* | 0.768 | ||
C-statistics | ||||
Derivation cohort | 0.864 | 0.865 | 0.842 | 0.866 |
Validation cohort | 0.870 | 0.876 | 0.849 | 0.875 |
Hosmer-Lemeshow test P | 0.558 | 0.909 | 0.418 | 0.623 |
AIC | 332.73 | 332.53 | 354.44 | 336.17 |
Notes.
- ACR
- Albumin-to-creatinine ratio
- eGFR
- Estimated glomerular filtration rate
- RASB
- renin-angiotensin system blocker
- AIC
- Akaike information criterion
statistically significant at P < 0.05.